Patent Assertion Entities: What the Evidence Shows

A study of 26 publicly traded patent assertion entities examines whether patent licensing firms undermine innovation or serve as technology intermediaries. Its findings challenge common assumptions about R&D investment, profitability, risk and the scale of their impact on the U.S. high-technology market.

Read More →